Salivary adenoid cystic carcinoma in Denmark 1990–2005: Outcome and independent prognostic factors including the benefit of radiotherapy. Results of the Danish Head and Neck Cancer Group (DAHANCA)

Highlights • A national Danish study presenting 201 patients with adenoid cystic carcinoma. • 10-year disease specific survival was 75%. • 36% experienced recurrence during follow-up (median 7.5 years). • The treatment of choice is surgery with free margins. • Adjuvant radiotherapy should be conside...

Full description

Saved in:
Bibliographic Details
Published in:Oral oncology 2015-12, Vol.51 (12), p.1138-1142
Main Authors: Bjørndal, Kristine, Krogdahl, Annelise, Therkildsen, Marianne H, Charabi, Birgitte, Kristensen, Claus A, Andersen, Elo, Schytte, Sten, Primdahl, Hanne, Johansen, Jørgen, Pedersen, Henrik B, Andersen, Lisbeth J, Godballe, Christian
Format: Article
Language:English
Subjects:
Adenoid cystic carcinoma
Adolescent
Adult
Aged
Aged, 80 and over
Carcinoma, Adenoid Cystic - mortality
Carcinoma, Adenoid Cystic - therapy
Child
Denmark - epidemiology
Female
Hematology, Oncology and Palliative Medicine
Humans
Male
Middle Aged
National
Neoplasm Recurrence, Local - mortality
Otolaryngology
Prognosis
Radiotherapy
Radiotherapy, Adjuvant
Salivary Gland Neoplasms - mortality
Salivary Gland Neoplasms - therapy
Survival Analysis
Treatment
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • A national Danish study presenting 201 patients with adenoid cystic carcinoma. • 10-year disease specific survival was 75%. • 36% experienced recurrence during follow-up (median 7.5 years). • The treatment of choice is surgery with free margins. • Adjuvant radiotherapy should be considered in selected patients.
ISSN:1368-8375
1879-0593
DOI:10.1016/j.oraloncology.2015.10.002